Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial - Dooley, Kelly E.; Miyahara, Sachiko; von Groote-Bidlingmaier, Florian; Sun, Xin; Hafner, Richard; Rosenkranz, Susan L.; Ignatius, Elisa H.; Nuermberger, Eric L.; Moran, Laura; Donahue, Kathleen; Swindells, Susan; Vanker, Naadira; et al. (American journal of respiratory and critical care medicine, 2020)
Keywords: Clinical trials; Drug dosages; Drug resistance; Multidrug resistant organisms; Original; Tuberculosis; phase 2 clinical trial; inhA mutation; early bactericidal activity; isoniazid resistance; tuberculosis